Some of the following articles are available freely, but a suitable Athens password, a journal subscription or one-off payment may be needed for access to the full-text of the other articles.
The Bibliographic Citations
Irwin, R.W. [and] Brinton, R.D. (2013). Allopregnanolone as regenerative therapeutic for Alzheimer’s Disease: translational development and clinical promise. Progress in Neurobiology. September 14th 2013. [Epub ahead of print]. Full Text Link.
Defina, P.A. Moser, R.S. Glenn, M. [et al]. (2013). Alzheimer’s Disease clinical and research update for health care practitioners. Journal of Aging Research. 2013; 207178. Epub September 4th 2013. Review. Full Text Link.
Tricco, A.C. Soobiah, C. Berliner, S. [et al]. (2013). Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis. CMAJ: Canadian Medical Association Journal. September 23rd 2013. [Epub ahead of print]. Full Text Link.
Sepehry, A.A. Lee, P.E. Hsiung, G.Y. [et al]. (2012). Effect of selective serotonin reuptake inhibitors in Alzheimer’s Disease with comorbid depression: a meta-analysis of depression and cognitive outcomes. Drugs and Aging. October 2012; 29(10): 793-806. Review.
Rainer, M. Mucke, H. [and] Schlaefke, S. (2013). Ginkgo biloba extract EGb 761 in the treatment of dementia: a pharmacoeconomic analysis of the Austrian setting. Wiener Klinische Wochenschrift. January 2013; 125(1-2): 8-15.
Yang, G. Wang, Y. Tian, J. [et al]. (2013). Huperzine A for Alzheimer’s Disease: a systematic review and meta-analysis of randomized clinical trials. PLoS One. September 23rd 2013; 8(9): e74916. Full Text Link.
Devos, D. Moreau, C. Dujardin, K. [et al]. (2013). New pharmacological options for treating advanced Parkinson’s Disease. Clinical Therapeutics. September 5th 2013. Full Text Link.
Weinstein, J.D. Gonzalez, E.R. Egleton, R.D. [et al]. (2013). A paradigm shift for evaluating pharmacotherapy for Alzheimer’s Disease: the 10-patient screening protocol. Consultant Pharmacist. July 2013; 28(7): 443-54.
van de Glind, E.M. van Enst, W.A. van Munster, B.C. [et al]. (2013). Pharmacological treatment of dementia: a scoping review of systematic reviews. Dementia and Geriatric Cognitive Disorders. 2013; 36(3-4): 211-28. Epub August 12th 2013. Full Text Link.
Nordberg, A. Ballard, C. Bullock, R. [et al]. (2013). A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer’s disease. Primary Care Companion to CNS Disorders. 2013; 15(2). Full Text Link.
Banerjee, S. Hellier, J. Romeo, R. [et al]. (2013). Study of the use of antidepressants for depression in dementia: the HTA-SADD trial: a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technology Assessment. February 2013; 17(7), 1-166. Full Text Link. There is an Executive Summary, a Protocol and a Research Summary for the Public.
[A version of this collection features in Dementia and Elderly Care: the Latest Evidence Newsletter (RWNHST), Volume 3 Issue 11, June 2014].
